{"title":"Defining the niche for stem-like CD8+ T cell formation and function","authors":"Benjamin J Broomfield , Joanna R Groom","doi":"10.1016/j.coi.2024.102454","DOIUrl":null,"url":null,"abstract":"<div><p>TCF-1<sup>+</sup> CD8<sup>+</sup> T cell populations have emerged as critical determinants for long-lived immunological memory. This cell population has stem-like properties and is implicated in improved disease outcomes by driving sustained killing of infected cells and maintaining the immune-cancer equilibrium. During an immune response, several factors, including antigen deposition and affinity, the inflammatory milieu, and T cell priming dynamics, aggregate to skew CD8<sup>+</sup> T cell differentiation. Although these mechanisms are altered between acute and chronic disease settings, phenotypically similar stem-like TCF-1<sup>+</sup> CD8<sup>+</sup> T cell states are formed in each of these settings. Here, we characterize the specialized microenvironments within lymph nodes and the tumor microenvironment, which foster the generation or re-activation of stem-like TCF-1<sup>+</sup> CD8<sup>+</sup> T cell populations. We highlight the potential for targeting the stem-like CD8<sup>+</sup> T cell niche to enhance vaccination and cancer immunotherapy and to track the trajectory of stem-like CD8<sup>+</sup> T cells as biomarkers of therapeutic efficacy.</p></div>","PeriodicalId":11361,"journal":{"name":"Current Opinion in Immunology","volume":"89 ","pages":"Article 102454"},"PeriodicalIF":6.6000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S095279152400044X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
TCF-1+ CD8+ T cell populations have emerged as critical determinants for long-lived immunological memory. This cell population has stem-like properties and is implicated in improved disease outcomes by driving sustained killing of infected cells and maintaining the immune-cancer equilibrium. During an immune response, several factors, including antigen deposition and affinity, the inflammatory milieu, and T cell priming dynamics, aggregate to skew CD8+ T cell differentiation. Although these mechanisms are altered between acute and chronic disease settings, phenotypically similar stem-like TCF-1+ CD8+ T cell states are formed in each of these settings. Here, we characterize the specialized microenvironments within lymph nodes and the tumor microenvironment, which foster the generation or re-activation of stem-like TCF-1+ CD8+ T cell populations. We highlight the potential for targeting the stem-like CD8+ T cell niche to enhance vaccination and cancer immunotherapy and to track the trajectory of stem-like CD8+ T cells as biomarkers of therapeutic efficacy.
TCF-1+ CD8+ T 细胞群已成为长效免疫记忆的关键决定因素。这种细胞群具有类似干细胞的特性,可持续杀伤感染细胞并维持免疫-癌症平衡,从而改善疾病预后。在免疫反应过程中,包括抗原沉积和亲和力、炎症环境和 T 细胞引物动力学在内的多种因素聚集在一起,使 CD8+ T 细胞分化发生偏移。虽然这些机制在急性和慢性疾病环境中有所改变,但在每种环境中都会形成表型相似的干型TCF-1+ CD8+ T细胞状态。在这里,我们描述了淋巴结和肿瘤微环境中促进干样TCF-1+ CD8+ T细胞群生成或再激活的特殊微环境。我们强调了靶向干样CD8+ T细胞生态位的潜力,以加强疫苗接种和癌症免疫疗法,并追踪干样CD8+ T细胞的轨迹,作为疗效的生物标志物。
期刊介绍:
Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.
In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.
Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.
Current Opinion in Immunology builds on Elsevier''s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists'' workflow.